NCT05333510

Brief Summary

Studies comparing Thromboelastography or Rotational thromboelastometry versus standard coagulation tests are abundant. Data comparing the two exclusively in a liver intensive care set up is limited. Studies show that TEG and ROTEM cannot be used interchangeably in trauma, liver transplant patients, but there is limited evidence of the same in critically ill cirrhotic patients. In this study, the investigators tried to demonstrate the comparison of blood products used to treat coagulopathy based on TEG versus ROTEM algorithms in cirrhotic patients presenting with non variceal bleeding

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 8, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 8, 2022

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

January 13, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 19, 2022

Completed
Last Updated

April 19, 2022

Status Verified

January 1, 2022

Enrollment Period

6 months

First QC Date

January 13, 2022

Last Update Submit

April 11, 2022

Conditions

Keywords

THROMBOELASTOGRAPHYTHROMBOELASTOMETRYnonvaricealbleeding

Outcome Measures

Primary Outcomes (1)

  • Total amount of blood products transfused at 8 hours(FFP, Cryoprecipitate, platelets) will be measured

    Total amount of blood products transfused at 8 hours(FFP, Cryoprecipitate, platelets) will be measured

    8 hours

Secondary Outcomes (10)

  • R time of thromboelastography

    8 hours

  • K time of thromboelastography

    8 hours

  • alpha angle of thromboelastography

    8 hours

  • Maximum amplitude of thromboleastography

    8 hours

  • LY30 Iin thromboelastometry

    8 hours

  • +5 more secondary outcomes

Study Arms (2)

TEG group

Thromboelastography guided blood product administration in patients of liver cirrhosis with non variceal bleed

ROTEM group

Throboelastometry guided blood product administration in patients of liver cirrhosis with non variceal bleed

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients of liver cirrhosis who are presenting with non variceal bleed would be included in this study

You may qualify if:

  • patients of liver cirrhosis with non variceal bleed

You may not qualify if:

  • Pregnant and postpartum patients
  • died within the first 24hours of admission.
  • variceal and postvariceal ligation ulcer bleed.
  • On anticoagulants or antiplatelets at the time of admission in ICU
  • Transfusion with blood products before admission to the ICU.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Liver and Biliary Sciences

New Delhi, National Capital Territory of Delhi, 110070, India

Location

Related Publications (4)

  • Premkumar M, Saxena P, Rangegowda D, Baweja S, Mirza R, Jain P, Bhatia P, Kumar G, Bihari C, Kalal C, Vyas T, Choudhury A, Sarin SK. Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute-on-chronic liver failure: An observational cohort study. Liver Int. 2019 Apr;39(4):694-704. doi: 10.1111/liv.14034. Epub 2019 Feb 7.

    PMID: 30589495BACKGROUND
  • Kumar M, Ahmad J, Maiwall R, Choudhury A, Bajpai M, Mitra LG, Saluja V, Mohan Agarwal P, Bihari C, Shasthry SM, Jindal A, Bhardwaj A, Kumar G, Sarin SK. Thromboelastography-Guided Blood Component Use in Patients With Cirrhosis With Nonvariceal Bleeding: A Randomized Controlled Trial. Hepatology. 2020 Jan;71(1):235-246. doi: 10.1002/hep.30794. Epub 2019 Aug 27.

    PMID: 31148204BACKGROUND
  • Wikkelso A, Wetterslev J, Moller AM, Afshari A. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD007871. doi: 10.1002/14651858.CD007871.pub3.

    PMID: 27552162BACKGROUND
  • Singh SA, Krishnan G, Ashraf H, Subramanian R, Pandey V, Nasa VK, Goyal S, Gupta S. Correlation between thromboelastography and rotational thromboelastometry values in adult liver transplant recipients. Indian J Anaesth. 2020 Apr;64(4):286-291. doi: 10.4103/ija.IJA_762_19. Epub 2020 Mar 28.

    PMID: 32489202BACKGROUND

MeSH Terms

Conditions

Liver CirrhosisHemorrhage

Condition Hierarchy (Ancestors)

Liver DiseasesDigestive System DiseasesFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • NIMI GOPAL

    Institute of Liver and Biliary Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 13, 2022

First Posted

April 19, 2022

Study Start

July 1, 2021

Primary Completion

January 8, 2022

Study Completion

January 8, 2022

Last Updated

April 19, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations